Long-Term Benefit for T+A in Live...
Long-Term Benefit for T+A in Liver Cancer confirmed with CHIEF data - Beyond the Trial

Liver Cancer Podcast by International Liver Cancer Association (ILCA)

Episode notes

Season 3 - Episode 10

In this episode, Dr. Manon Allaire, a physician at La Pitié-Salpêtrière Hospital in Paris, shares her perspective on evolving approaches in liver cancer care. Using the CHIEF data as a starting point, the discussion looks beyond the trial to reflect on how emerging evidence is interpreted in clinical practice. Dr. Allaire offers a thoughtful overview of key considerations, ongoing questions, and what these discussions may mean for the future of treatment.

Keywords
liver cancerclinical trialshccsystemic therapycell biologyhepatocellular carcinoma